Sessions

Characterization of a Novel TRPC1/4/5 Channel Blocker (Pico145)

[Speaker] Hussein N Rubaiy:1
[Co-author] Mathias Christmann:2, Katsuhiko Muraki:3, David J Beech:4
1:Centre for Atherothrombosis and Metabolic Disease, University of Hull, UK, 2:Institute of Chemistry and Biochemistry, Freie Universitat Berlin, Germany, 3:Faculty of Life Sciences, Kyoto Sangyo University, Japan, 4:Schools of Medicine, University of Leeds, UK

SGK1 inhibition as potential anti-inflammatory therapeutics targeting hypertensive cardiac fibrosis

[Speaker] Min Yang:1
[Co-author] Wenqiang Gan:1, Tiegang Li:1
1:Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, China

Unique functions of ryanodine type3 in vascular and myometrial smooth muscles

[Speaker] Yuji Imaizumi:1
[Co-author] Katsuhito Matsuki:1, Yoshiaki Suzuki:1, Hisao Yamamura:1, Susumu Ohya:2, Hiroshi Takeshima:3
1:Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan, 2:Department of Pharmacology, Graduate School of Medicine, Nagoya City University, Japan, 3:Department of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Japan

Cardiac myofibroblasts engulf dead cells generated in hearts with hypertrophy

[Speaker] Shoichi Matsuda:1
[Co-author] Michio Nakaya:1, Shiori Komiya:1, Akiomi Nagasaka:1, Hitoshi Kurose:1
1:Department of Pharmacology and Toxicology, Graduate School of Pharmaceutical Science, Kyushu University, Japan

Understanding the polypharmacology of Proteinase-activated receptor (PAR) pepducins and investigating their biophysical association using mass spectrometry imaging (MSI) technologies

[Speaker] Margaret R Cunningham:1
1:Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, UK

Advanced Search